NDC 59667-0060

Menstrual Cramps Back

Ammonium Carb 30c, Borax 30c, Calcarea Phosphorica 30c, Chamomilla 30c, Cimicifuga 30c, Gelsemium 30c, Helonius 30c, Kali Carb 30c, Nux Vomica 30c Pulsatilla 30c, Senecio 30c, Xanthum 30c

Menstrual Cramps Back is a Oral Spray in the Human Otc Drug category. It is labeled and distributed by Home Sweet Homeopathics. The primary component is Ammonium Carbonate; Sodium Borate; Tribasic Calcium Phosphate; Matricaria Recutita; Black Cohosh; Gelsemium Sempervirens Root; Chamaelirium Luteum Root; Potassium Carbonate; Strychnos Nux-vomica Seed; Pulsatilla Vulgaris; Packera Aurea; Zanthoxylum Americanum Bark.

Product ID59667-0060_e453932f-7a53-4732-81fd-f053440be1aa
NDC59667-0060
Product TypeHuman Otc Drug
Proprietary NameMenstrual Cramps Back
Generic NameAmmonium Carb 30c, Borax 30c, Calcarea Phosphorica 30c, Chamomilla 30c, Cimicifuga 30c, Gelsemium 30c, Helonius 30c, Kali Carb 30c, Nux Vomica 30c Pulsatilla 30c, Senecio 30c, Xanthum 30c
Dosage FormSpray
Route of AdministrationORAL
Marketing Start Date2013-08-02
Marketing CategoryUNAPPROVED HOMEOPATHIC / UNAPPROVED HOMEOPATHIC
Labeler NameHome Sweet Homeopathics
Substance NameAMMONIUM CARBONATE; SODIUM BORATE; TRIBASIC CALCIUM PHOSPHATE; MATRICARIA RECUTITA; BLACK COHOSH; GELSEMIUM SEMPERVIRENS ROOT; CHAMAELIRIUM LUTEUM ROOT; POTASSIUM CARBONATE; STRYCHNOS NUX-VOMICA SEED; PULSATILLA VULGARIS; PACKERA AUREA; ZANTHOXYLUM AMERICANUM BARK
Active Ingredient Strength30 [hp_C]/30[hp_C]; [hp_C]/30[hp_C]; [hp_C]/30[hp_C]; [hp_C]/30[hp_C]; [hp_C]/30[hp_C]; [hp_C]/30[hp_C]; [hp_C]/30[hp_C]; [hp_C]/30[hp_C]; [hp_C]/30[hp_C]; [hp_C]/30[hp_C]; [hp_C]/30[hp_C]; [hp_C]/30[hp_C]
NDC Exclude FlagE
Listing Certified Through2017-12-31

Packaging

NDC 59667-0060-2

30 [hp_C] in 1 BOTTLE, SPRAY (59667-0060-2)
Marketing Start Date2013-08-02
NDC Exclude FlagN
Sample Package?N

NDC SPL Data Element Entries

NDC 59667-0060-2 [59667006002]

Menstrual Cramps Back SPRAY
Marketing Categoryunapproved homeopathic
Product TypeHUMAN OTC DRUG
Marketing Start Date2013-08-02
Inactivation Date2019-11-27

Drug Details


© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.